Dec 01, 2022 / 08:00PM GMT
Ted Tenthoff - Piper Sandler Companies - Analyst
Great. Good afternoon, everyone. My name is Ted Tenthoff. I'm a Senior Biotech Analyst at Piper Sandler. I want to thank you all for sticking around for the last presenting company of the 2022 Healthcare Conference. Drum roll.
Before I begin, I am required to point out certain disclosures regarding the relationship between Piper and our next presenting company, Molecular Templates, which are posted both in the back of the room and also down at the registration desk.
So Molecular Templates is developing engineered toxin bodies or ETBs, which use an antibody fusion or an antibody domain, pardon me, fused to a genetically engineered version of the Shiga-like toxin. MTEM is advancing a rich pipeline of ETBs, and also has a partnership including with Bristol Myers Squibb. Joining us today is Eric Poma, CEO and Chief Scientific Officer. Eric, thanks for being with us.
Eric Poma - Molecular Templates, Inc. - CEO & Chief Scientific Officer
Yes, thank you for the invite. It's been a great conference;
Molecular Templates Inc at Piper Sandler Healthcare Conference Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers